|Monday, October 25th – Thursday, October 28th
Outcome Capital is actively participating in partneringONE at the 2021 session of BIO-Europe. Join Managing Directors Dr. John Armstrong & Dr. Ellen Baron to discuss how outcome can help with your strategic & financial advisory needs for M&A, strategic partnering & equity capital raises.
September 13, 2021 Vancouver, British Columbia & Boston, MA. AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, today announced it has acquired TetraGenetics, Inc. (TetraGenetics), a biotechnology company with a proprietary platform for generating recombinant human ion channels and other transmembrane proteins, in an all-cash transaction that includes […]Read More
June 17, 2021 09:40 AM Eastern Daylight Time BOSTON, MA–(BUSINESS WIRE)–Outcome Capital, a specialized advisory and investment banking firm that serves middle market companies in the life science and technology segments, today announced that Veranex, a newly formed concept-to-commercialization service provider dedicated to the medtech industry, has acquired Boston Healthcare Associates (BHA), a global strategy […]Read More
Outcome Capital Life Science Market Pulse September 2021 Click to view our LifeSciences Pulse NewsletterDownload